Phaarmasia Limited

₹82.00As of Sun 8 Nov 2026, 12:00 UTC
BSE:523620Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 16.08%
Div yield —
ROE 113.99%
Pharmaceutical Preparations
Beta (5Y) 0.85
PE TTM 3.176
TSR TTM 143.54%
Mkt cap ₹559.8M
ROIC 17.40%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹89
8.29%
272.89%
Hold 2|10|7|9|6
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
1.28
1.22
1.27
1.36
21.58%
15.38%
16.03%
18.44%
Revenue₹M
24.95
25.06
26.48
25.85
(2.53%)
(0.73%)
7.80%
7.34%
Peers (US$5.961M)
Cap (US$)
PE
5.881M
—
Capital
TTM
5Y
10Y
Leveragex
0.727
0.433
0.449
EBIT/Intx
3.196
1.655
1.477
Own earn%
(29.37)
(17.29)
(24.31)
Sh yield%
22.09
28.53
29.80
Owners
Insiders/Inst%
7.62
76.77
Short interest%
2.39
SBC / revenue%
3.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
13–26
$1 testx
0.5
Incr. ROIC%
2